RAPS Approved Seminar on Complying with GMP and cGMP Requirements: Streamlining Quality Assurance and FDA Compliance at Mumbai

Overview: Each lecture will be 90 min in length. There will be morning and afternoon breaks of 30 min each which will be reduced to 15 min, if needed to accommodate long lectures. Lunch will be at least 1 hr in length.

The instructor will be available for questions and discussions during all breaks and lunches and will also be available for a minimum of 30 min at the end of each day.

The first day’s presentations will be for those who are new to the U.S. regulations. The second day’s presentations will be aimed at people in Regulatory Affairs or Clinical Studies, and the third day’s presentations will be directed at those who have some prior knowledge of the regulations.

Seminar Content:  India Seminar 2012 at Mumbai

  Day 1 - 18th June 2012

·         Lecture 1: Introduction to U.S. Drug Regulation

·         Lecture 2: Laws and Regulations in the U.S

·         Lecture 3: The U.S. Drug GMP- Part 1

·         Lecture 4: The U.S. Drug GMP – Part 2

Day 2 - 19th June 2012

·         Lecture 5: Violations and Responses

·         Lecture 6: Filings and Submissions - DMF and Clinical Trials

·         Lecture 7: Filings and Submissions – NDA and BLA

·         Lecture 8: Inspections and Audits

Day 3 - 20th June 2012

·         Lecture 9: An Overview of ICH Q8,Q9, and Q10

·         Lecture 10: Risk Analysis and Corrective and Preventive Actions (CAPA)

·         Lecture 11: Biosimilars in the U.S., An Overview

·         Lecture 12: Process Validation

 Who Will Benefit:

• Presidents
• Vice Presidents of Technical Departments
• Managers
• Directors
• Regulatory Associates and Analysts
• Quality
• Regulatory
• Research
• Development Group Heads

About Speaker:

Dr. Steven S Kuwahara currently heads GXP BioTechnology .  He is an experienced analytical biochemist who has applied his knowledge to the quality control area of pharmaceuticals. His work has dealt with all aspects of GMP and GLP in relation to drugs and biopharmaceuticals. He has worked with small molecules, proteins, cells, gene therapy vectors and nutritional supplements.

Dr. Kuwahara has written many papers and book chapters, and serves on the editorial advisory boards of BioPharm, BioQuality, Journal of Validation Technology, and Journal of GXP Compliance. For the last of these, he also writes a column called “The GLP Forum.”

He has held certifications such as CQA, CQT, and CQE from the American Society of Quality, and was certified RAC by the Regulatory Affairs Professionals Society.

DATE AND VENUE:

18th, 19th and 20th June, 2012 at Mumbai

Conference Timings: 9:00 am - 6:00 pm

Price – Rs18000

Contact Information:

Event Coordinator

Toll free: 1800 425 9409

Phone number: +91 80-3221-3341 / +91 80-3247-3696 /+91 80-3221-3329.

FAX : +91 80-2642-1483

Email: customersupport@globalcompliancepanel.com

GlobalCompliancePanel

NetZealous Services India Pvt. Ltd.

4th Floor, A, Block, Brigade Software Park,

Banashankari 2nd stage,

Bangalore-560070. INDIA.